Cardiovascular Medicine: New Therapeutic Drugs Approved by the US FDA (2013?2017)

Author:   Y Robert Li
Publisher:   Aimsci Inc.
ISBN:  

9781680560039


Pages:   266
Publication Date:   11 March 2018
Format:   Paperback
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Our Price $343.07 Quantity:  
Add to Cart

Share |

Cardiovascular Medicine: New Therapeutic Drugs Approved by the US FDA (2013?2017)


Overview

"Written in an accessible style and consistent format, ""Cardiovascular Medicine: New Therapeutic Drugs Approved by the US FDA (2013-2017)"" takes a unique approach to integrating the fundamental concepts with high quality cutting-edge research discoveries and translating essential bioscience to evidence-based clinical medicine so as to provide the reader a comprehensive picture of this rapidly evolving field in a concise manner. Blends basic and clinical sciences needed to effectively demonstrate the importance of the field Includes full-color illustrations to facilitate the understanding of the essential concepts Cites references mostly from highly influential journals to ensure the top quality of the information Uses chapter highlights and self-assessment questions to enhance the assimilation of the cutting-edge knowledge Serves as a valuable reference or textbook for students, faculty, clinicians, and other health professionals in the fields of biomedical science, pharmacology, pharmacotherapeutics, and clinical medicine"

Full Product Details

Author:   Y Robert Li
Publisher:   Aimsci Inc.
Imprint:   Aimsci Inc.
Dimensions:   Width: 21.60cm , Height: 1.80cm , Length: 27.90cm
Weight:   0.862kg
ISBN:  

9781680560039


ISBN 10:   1680560034
Pages:   266
Publication Date:   11 March 2018
Audience:   General/trade ,  General
Format:   Paperback
Publisher's Status:   Active
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Table of Contents

Reviews

Author Information

"Y. Robert Li, MD, MPH, PhD, is Professor and Chair of Pharmacology at Campbell Medical School and Adjunct Professor at several other major universities, including Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences, Department of Biomedical Sciences and Pathobiology of Virginia Polytechnic Institute and State University, and Department of Biology of University of North Carolina at Greensboro. He is an internationally recognized expert in free radical and cardiovascular research. Y. Robert Li is also Co-Editor-in-Chief of Toxicology Letters, a well-respected international journal published by Elsevier and editorial board member for a number of major scholarly journals. He is author of over 130 peer-reviewed journal articles and his research has been funded extensively by the United States National Institutes of Health. Other recent books of Y. Robert Li include the widely adopted ""Free Radical Biomedicine: Principles, Clinical Correlations, and Methodologies""; ""Antioxidants in Biology and Medicine: Essentials, Advances, and Clinical Applications""; ""Cardiovascular Diseases: From Molecular Pharmacology to Evidence-Based Therapeutics""; ""Biomedical Research: Strategic Planning for Success"", and ""Essentials of Free Radical Biology and Medicine""."

Tab Content 6

Author Website:  

Countries Available

All regions
Latest Reading Guide

NOV RG 20252

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List